Palvella Puts U.S. DSAP Population at 154,986 in New Posters
Palvella Therapeutics posters estimate 154,986 U.S. patients with disseminated superficial actinic porokeratosis, sharpening the epidemiological picture for the rare skin disease.
Topic
Palvella Therapeutics
Topic
Palvella Therapeutics
Palvella Brings Clinical and Claims Data to Dermatology Conference Stage
Palvella Therapeutics presented clinical and claims data at a dermatology conference, pairing trial results with real-world analy…
Palvella to Present Three Posters on Microcystic Lymphatic Malformations and DSAP
Palvella Therapeutics will present three posters with new data on microcystic lymphatic malformations and DSAP at Fall Clinical D…